Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

22 ene 2018 7:00 a.m. - 24 ene 2018 5:00 p.m.

2500 Calvert Street NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 9: Advanced Technologies

Session Chair(s)

Stephen  Knowles, MD, MRCP

Stephen Knowles, MD, MRCP

Chief Medical Officer

Halozyme Therapeutics, United States

The use of advanced technologies in the management of chronic diseases and monitoring patients in clinical trials is increasing. For example, the use of mobile apps to aid the control of diabetes, the use of wearable technologies to monitor patient sleep and activity during clinical trials, and implantable biosensors which allow continuous monitoring of body chemicals. This session will bring scientific expert and patient perspectives together in a discussion of these new technologies and the impact they are having, and will have, on patient monitoring and patient experience.

Speaker(s)

Gary K. Zammit, PhD, MS

The Use of Wearable Technologies in Clinical Trials to Monitor Movement and Sleep/Wake Patterns

Gary K. Zammit, PhD, MS

Clinilabs Drug Development Corporation, United States

President and CEO

Sara  Loud, MBA, MS

Breakthrough or Big Brother? Thoughts on Advanced Technologies and Data Sharing from the Multiple Sclerosis Community

Sara Loud, MBA, MS

Accelerated Cure Project, United States

Chief Operating Officer

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.